Two broadly neutralizing antibodies show great promise to provide long-acting immunity against COVID-19 in immunocompromised populations according to a paper published June 15 in the Journal of Experimental Medicine (JEM). The antibodies were effective against all SARS-CoV-2 variants of concern tested and could be used alone or in an antibody cocktail to diminish the risk of infection.
Broadly neutralizing antibodies could provide immunity against SARS-CoV-2 variants
June 16, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022